MorphoSys AG
MPSYF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $27,540 | $59,078 | $63,800 | $53,165 |
| % Growth | -53.4% | -7.4% | 20% | – |
| Cost of Goods Sold | $3,867 | $14,555 | $15,100 | $7,701 |
| Gross Profit | $23,673 | $44,523 | $48,700 | $45,464 |
| % Margin | 86% | 75.4% | 76.3% | 85.5% |
| R&D Expenses | $85,151 | $80,314 | $63,200 | $57,008 |
| G&A Expenses | $185,534 | $43,318 | $15,000 | $16,977 |
| SG&A Expenses | $202,943 | -$9,162 | $34,900 | $39,000 |
| Sales & Mktg Exp. | $18,452 | -$52,480 | $19,900 | $22,023 |
| Other Operating Expenses | $0 | -$832 | $0 | $70 |
| Operating Expenses | $288,094 | $125,780 | $98,100 | $96,008 |
| Operating Income | -$264,421 | -$81,376 | -$51,000 | -$50,544 |
| % Margin | -960.1% | -137.7% | -79.9% | -95.1% |
| Other Income/Exp. Net | -$52,124 | $127,953 | -$68,100 | $6,780 |
| Pre-Tax Income | -$316,545 | $46,577 | -$119,100 | -$43,764 |
| Tax Expense | -$1,583 | -$1,689 | $500 | $30,203 |
| Net Income | -$314,963 | $48,266 | -$119,600 | -$73,967 |
| % Margin | -1,143.7% | 81.7% | -187.5% | -139.1% |
| EPS | -8.27 | 1.28 | -3.5 | -2.16 |
| % Growth | -746.1% | 136.6% | -62% | – |
| EPS Diluted | -8.27 | 1.22 | -3.5 | -2.16 |
| Weighted Avg Shares Out | 37,618 | 39,603 | 34,171 | 34,167 |
| Weighted Avg Shares Out Dil | 37,618 | 39,590 | 34,171 | 34,167 |
| Supplemental Information | – | – | – | – |
| Interest Income | $63 | $84,704 | $1,264 | $6,594 |
| Interest Expense | $2,834 | $0 | $67,100 | $28,321 |
| Depreciation & Amortization | $1,043 | $2,059 | $2,734 | $2,979 |
| EBITDA | -$307,290 | $52,280 | -$50,902 | -$42,666 |
| % Margin | -1,115.8% | 88.5% | -79.8% | -80.3% |